Cancer BiologyJCI InsightPeer-reviewed
Development and Characterization of Triazole-Based WDR5 Inhibitors for the Treatment of Glioblastoma
Jesse A. Coker, Steven R. Martinez, Sang Hoon Han…·Shaun R. Stauffer
This study develops triazole-based WDR5 inhibitors that show improved brain penetration and antiproliferative activity against glioblastoma CSCs, with synergistic effects when combined with ATAD2 inhibitors.
DOI 10.1172/jci.insight.198298